These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3378609)

  • 41. Study of the fibrinolytic process in a patient with antiphospholipid syndrome.
    Marchi R; Garmendia J; Kanzler D; Fuenmayor J
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):239-45. PubMed ID: 24418942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reflex reaction of the anticlotting system to DIP-alpha-thrombin devoid of blood clotting activity].
    Kudriashov BA; Strukova SM; Mitroshina TN; Umarova BA
    Fiziol Zh SSSR Im I M Sechenova; 1981 Jul; 67(7):1021-6. PubMed ID: 7286316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of erythropoietin on activity of plasma proteolytic systems during experimental renal failure.
    Osikov MV; Grigoriev TA
    Bull Exp Biol Med; 2012 May; 153(1):21-4. PubMed ID: 22808484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Vopr Med Khim; 1978; 24(2):255-60. PubMed ID: 149422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Change in plasma esterase activity during stimulation of the "2d anticoagulation system"].
    Baskova IP; Cherkesova DU; Orlova AS; Kudriashov BA
    Vopr Med Khim; 1974; 20(5):482-9. PubMed ID: 4456798
    [No Abstract]   [Full Text] [Related]  

  • 47. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator.
    Fassbender K; Dempfle CE; Mielke O; Schwartz A; Daffertshofer M; Eschenfelder C; Dollman M; Hennerici M
    Stroke; 1999 Oct; 30(10):2101-4. PubMed ID: 10512913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [In vitro effect of Iopamidol on coagulation, fibrinolysis and complement system (author's transl)].
    Schulze B; Beyer HK
    Arzneimittelforschung; 1981; 31(7):1067-9. PubMed ID: 7196754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of five Thai snake venoms on coagulation, fibrinolysis and platelet aggregation.
    Mitrakul C
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):266-75. PubMed ID: 524153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Role of cholino- and adrenoreceptors in regulating blood coagulation and fibrinolysis following thrombin injections].
    Mishchenko VP; Kuznik BI
    Fiziol Zh SSSR Im I M Sechenova; 1976 Nov; 62(11):1614-21. PubMed ID: 1022534
    [No Abstract]   [Full Text] [Related]  

  • 51. On the interaction of heparin-containing polymers with plasma proteins and blood.
    Platé NA; Valuev LI
    Thromb Res; 1982 Jul; 27(2):131-41. PubMed ID: 7135350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 53. Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi.
    Nielsen VG
    J Thromb Thrombolysis; 2016 Jul; 42(1):33-7. PubMed ID: 26407681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis.
    van Geffen M; Loof A; Lap P; Boezeman J; Laros-van Gorkom BA; Brons P; Verbruggen B; van Kraaij M; van Heerde WL
    Hematology; 2011 Nov; 16(6):327-36. PubMed ID: 22183066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Disorders of the coagulation, fibrinolytic and kallikrein-kinin systems of the blood in mechanical jaundice].
    Artem'eva NN; Sitkevich RV; Chalenko VV; Zlatin GS; Chalenko IO
    Vestn Khir Im I I Grek; 1986 Aug; 137(8):31-7. PubMed ID: 2429428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of euglobulin clot lysis time as a screening method for determination of blood plasma fibrinolytic activity after venous occlusion.
    Boberg M; Killander A
    Acta Med Scand; 1983; 213(4):309-11. PubMed ID: 6613690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of low-density lipoproteins on blood coagulation and fibrinolytic activity.
    Azizova OA; Roitman EV; Dement'eva II; Nikitina NA; Gagaeva EV; Lopukhin YM
    Bull Exp Biol Med; 2000 Jun; 129(6):541-4. PubMed ID: 11022243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global assays of fibrinolysis.
    Ilich A; Bokarev I; Key NS
    Int J Lab Hematol; 2017 Oct; 39(5):441-447. PubMed ID: 28497494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 60. Thrombin and acetylated thrombin in the activation of fibrinolysis.
    Landaburu RH; Giavedoni E; Santillán R
    Can J Physiol Pharmacol; 1968 Nov; 46(6):809-13. PubMed ID: 5698925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.